Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.41 |
| ▸ | PREP | P48147 | 5/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.39 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.39 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.38 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26425956 | 0.79 | DPP4 (0.48) | MTNR1APREPMEN1KMT2ASIGMAR1 | |
| SCHEMBL26428548 | 0.77 | DPP4 (0.52) | PREPMEN1KMT2A | |
| SCHEMBL26429246 | 0.72 | DPP4 (0.48) | SIGMAR1 | |
| SCHEMBL26429036 | 0.70 | GRM2 (0.43) | MTNR1APREPGRM2GRM3 | |
| SCHEMBL24158329 | 0.70 | PREP (0.53) | PREPMEN1KMT2A | |
| SCHEMBL9774278 | 0.69 | ACE (0.54) | PREPMEN1KMT2A | |
| SCHEMBL11958401 | 0.69 | KMT2A (0.59) | MEN1KMT2A | |
| SCHEMBL961507 | 0.68 | MTNR1A (0.63) | MTNR1AMEN1KMT2AP2RX7 | |
| SCHEMBL9773813 | 0.68 | ACE (0.55) | PREPMEN1KMT2A | |
| SCHEMBL15229937 | 0.67 | KMT2A (0.56) | MTNR1AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4170347-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2023-04-26 | — | — | EP | disclosed |